Alvotech

Healthcare

NASDAQ:ALVO · NASDAQ Global Market

Market Cap $1.29B Beta 0.21 P/E (TTM) -17.1

$4.17 -1.18%

-$0.05 today

52W Low $2.94High $9.94

Vol 0.53M · Avg 0.57M

EPS (TTM)-$0.24

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-57.19%

Period High

$9.81

Period Low

$3.00

Latest

$4.17

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Progyny, Inc.

NASDAQ:PGNY

$2.09B

Select Medical Holdings Corporation

NYSE:SEM

$2.07B

UFP Technologies, Inc.

NASDAQ:UFPT

$1.82B

Harrow Health, Inc.

NASDAQ:HROW

$1.40B

Phibro Animal Health Corporation

NASDAQ:PAHC

$1.28B

Biohaven Ltd.

NYSE:BHVN

$1.19B

Collegium Pharmaceutical, Inc.

NASDAQ:COLL

$1.12B

Evotec SE

NASDAQ:EVO

$966.11M

Amphastar Pharmaceuticals, Inc.

NASDAQ:AMPH

$885.83M

Tilray Brands, Inc.

NASDAQ:TLRY

$595.63M

What is the latest ALVO filing?

The latest filing shown is 6-K dated Jun 8, 2026.

How many recent filings does ALVO have?

Intrinsic Alpha currently shows 20 recent filings for ALVO.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.